Literature DB >> 8270930

Investigation of the opioid system in absence seizures with positron emission tomography.

P A Bartenstein1, J S Duncan, M C Prevett, V J Cunningham, D R Fish, A K Jones, S K Luthra, G V Sawle, D J Brooks.   

Abstract

The neuroanatomical and pathophysiological basis of primary generalised absences is uncertain. Administration of endogenous opioids has been shown to result in absence-like seizures in animal models. Positron emission tomography scans were performed in eight patients with primary generalised epilepsy and eight control subjects. Regional cerebral blood flow was measured interictally with C15O2, after which a 90 minute dynamic study with the opioid-receptor ligand 11C-diprenorphine was performed. Serial absences were precipitated by hyperventilation for 10 minutes, starting 30-40 minutes after injection of diprenorphine. Absences, with generalised spike-wave discharges on the EEG, occurred for between 10% and 51% of the provocation period. No individual (normal or patient) had any interictal focal abnormalities of cerebral blood flow. After provocation of serial absence seizures, there was increased diprenorphine elimination from the association cortex, but not from the thalamus, basal ganglia, or cerebellum, compared with control subjects and patients scanned without provocation of absences. It was possible to simulate the observed increased diprenorphine elimination following seizures in cerebral cortex using a two tissue compartment model, with an estimated 15-41% decrease in the specific tracer uptake rate constant (k3). These results suggest that endogenous opioids are released in the association cortex at the time of serial absences, lead to increased receptor occupancy, and may have an important role in the pathophysiology of generalised absences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270930      PMCID: PMC1015377          DOI: 10.1136/jnnp.56.12.1295

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Increased methionine-enkephalin levels in genetically epileptic (tg/tg) mice.

Authors:  V K Patel; L C Abbott; A K Rattan; G A Tejwani
Journal:  Brain Res Bull       Date:  1991-12       Impact factor: 4.077

2.  Selectivity in the control of opiate receptor density in the animal and in cultured fetal brain cells.

Authors:  R Simantov; J Lotem; R Levy
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

3.  Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks.

Authors:  A R Green; E Peralta; J S Hong; C C Mao; C K Atterwill; E Costa
Journal:  J Neurochem       Date:  1978-09       Impact factor: 5.372

4.  Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure.

Authors:  F C Tortella; J B Long
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

5.  Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin.

Authors:  O C Snead; L J Bearden
Journal:  Science       Date:  1980-11-28       Impact factor: 47.728

6.  Studies on opioid peptides as endogenous anticonvulsants.

Authors:  F C Tortella; A Cowan
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

7.  Changes of hippocampal Met-enkephalin content after recurrent motor seizures.

Authors:  J S Hong; P L Wood; J C Gillin; H Y Yang; E Costa
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

8.  Positron emission tomography in generalized seizures.

Authors:  W H Theodore; R Brooks; R Margolin; N Patronas; S Sato; R J Porter; L Mansi; D Bairamian; G DiChiro
Journal:  Neurology       Date:  1985-05       Impact factor: 9.910

9.  In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.

Authors:  M L Richards; W Sadée
Journal:  Eur J Pharmacol       Date:  1985-08-27       Impact factor: 4.432

10.  Amygdaloid kindling enhances the enkephalin content in the rat brain.

Authors:  O Vindrola; R Briones; M Asai; A Fernández-Guardiola
Journal:  Neurosci Lett       Date:  1981-01-01       Impact factor: 3.046

View more
  9 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  The role of positron emission tomography within the spectrum of medical imaging.

Authors:  T Jones
Journal:  Eur J Nucl Med       Date:  1996-02

3.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 4.  Imaging the head: functional imaging.

Authors:  G V Sawle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 5.  From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Authors:  George B Richerson; Detlev Boison; Carl L Faingold; Philippe Ryvlin
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

Review 6.  PET studies in epilepsy.

Authors:  Ismet Sarikaya
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 7.  Imaging of opioid receptors in the central nervous system.

Authors:  Gjermund Henriksen; Frode Willoch
Journal:  Brain       Date:  2007-11-29       Impact factor: 13.501

Review 8.  Advances of Molecular Imaging in Epilepsy.

Authors:  Marian Galovic; Matthias Koepp
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 9.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.